MediConnect STO (MEDI)

Invest in the future of medicine online and help ensure the safety of the patient on and offline.

MediConnect is a safety net for patients, prescribers, pharmacies and drug manufacturers.
Our vision is to become the gold standard blockchain solution approved by the Pharmacy and Medicine regulators for the prevention of obtaining multiple prescriptions from online and offline pharmacies.

Start Date

20 Feb, 2019

End Date

03 Apr, 2019

MediConnect Use of Token

MediConnect is the only blockchain solution intended to revolutionise the use of medication in the UK. It will prevent the over-prescribing to patients of medication from multiple pharmacies, reduce addiction, provide traceability of drugs from manufacturers, wholesalers, prescribers and pharmacies all the way through to patients. This will enable the removal of false medicines and the easy recall of drugs within the Pharma system.

  • Organization

    MediConnect

  • Platform

    Stratis

  • Coin type

    Security Token

  • Category

    Healthcare

  • Soft cap

    5,000,000

  • Max cap

    31,000,000

  • Max supply

MediConnect Token Sale Stages

  • Stage
  • Start date
  • End date
  • Amount of Tokens
  • Price
  • Discount
    • Private Sale
    • 16 January, 2019
    • 06 February, 2019
    • 20
    • Claim
    • Public Sale
    • 20 February, 2019
    • 03 April, 2019
    • Claim

MediConnect Distribution

MediConnect Use of Proceeds

MediConnect Team Members

  • Dexter Blackstock
    Dexter Blackstock Mediconnect Director
  • Joe Soiza
    Joe Soiza UK Meds Owner and Healthcare Visionary
  • Jason Timms
    Jason Timms PHZ Group Owner & Visionary
  • Shyam Morjaria
    Shyam Morjaria Superintendent Pharmacist & Head of Purchasing
  • Eddie Dandy
    Eddie Dandy Superintendent Pharmacist

MediConnect Advisors

  • Samuel Ogunsalu
    Samuel Ogunsalu Advisor

MediConnect Past Events

  • 31 March, 2019

    Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database

  • 30 June, 2019

    Agreed blockchain platform partnership with Stratis

  • 30 September, 2019

    Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee

  • 31 December, 2019

    Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction

  • 31 December, 2019

    Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect

  • 31 December, 2019

    Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups

  • 31 March, 2019

    ICO Public Sale

  • 31 March, 2019

    PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry

  • 30 June, 2019

    Commence contract with the ASC to support the Nottingham Trial and UK roll out programme

  • 30 June, 2019

    Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect

  • 30 June, 2019

    6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy

  • 30 September, 2019

    Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester

  • 30 September, 2019

    Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system

  • 31 December, 2019

    Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry